Retraction: Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect. . PLoS One 2026;21:e0341199.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Retraction: Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect. PLoS One 2026;21:e0341199.
PMID: 41544037